125 related articles for article (PubMed ID: 28621226)
1. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.
Khalid A; Hussain T; Manzoor S; Saalim M; Khaliq S
Tumour Biol; 2017 Jun; 39(6):1010428317705754. PubMed ID: 28621226
[TBL] [Abstract][Full Text] [Related]
2. [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].
Guo SP; Wang L; Wang WL; Li QL; Wang WY; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):467-72. PubMed ID: 17069699
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells.
Chung TW; Lee YC; Ko JH; Kim CH
Cancer Res; 2003 Jul; 63(13):3453-8. PubMed ID: 12839924
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
5. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
[TBL] [Abstract][Full Text] [Related]
6. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.
Wang H; Kohashi K; Yoshizumi T; Okumura Y; Tanaka Y; Shimokawa M; Iwasaki T; Aishima S; Maehara Y; Oda Y
Hum Pathol; 2017 Jun; 64():69-75. PubMed ID: 28411180
[TBL] [Abstract][Full Text] [Related]
9. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
10. [PTEN induces apoptosis and up-regulates p53 expression in HepG2 cells].
Yang ZF; Yi JL; Li XR; Xie DX; Liao XF; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):745-8. PubMed ID: 15619344
[TBL] [Abstract][Full Text] [Related]
11. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B virus X protein suppresses adriamycin-induced apoptosis of hepatocellular carcinoma cells and expression of p53 and PTEN].
Wang X; Yang L; She JJ; Fan HM; Zhang FC; Chen YM; Xie QF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1775-8. PubMed ID: 20813662
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
15. Association of 32-bp deletion polymorphism and promoter methylation of
Badawy AA; El-Rabat A; Elshazly TA; Ali SA; Alruwaili AM; Gad DF; Dawoud MG; Elmasry EE; Zaki ME
Br J Biomed Sci; 2019 Oct; 76(4):195-197. PubMed ID: 31109254
[No Abstract] [Full Text] [Related]
16. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
Yang H; Zheng W; Zhao W; Guan C; An J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB.
Zhang Y; Li RQ; Feng XD; Zhang YH; Wang L
Int J Clin Exp Pathol; 2014; 7(11):7351-9. PubMed ID: 25550771
[TBL] [Abstract][Full Text] [Related]
19. PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer.
Peyrou M; Bourgoin L; Foti M
Dig Dis; 2010; 28(1):236-46. PubMed ID: 20460918
[TBL] [Abstract][Full Text] [Related]
20. Impaired phosphate and tension homologue deleted on chromosome 10 expression and its prognostic role in radical surgery for hepatocellular carcinoma with family aggregation resulting from hepatitis B and liver cirrhosis.
Zhong Y; Yan J; Deng M; Hu K; Yao Z; Zou Y; Xu R
Exp Biol Med (Maywood); 2013 Aug; 238(8):866-73. PubMed ID: 23828588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
